European scientific associations unite to tackle animal research directive (Alphagalileo, 10 November)

Synthetic hormone may boost heart risks in kidney patients (LATimes, via NEJM, 16 Nov 2006)

Drug watchdog backs new breast cancer drugs (Reuters, 22 Nov 2006)

23 Nov 2006

Medicines cost-effectiveness watchdog NICE has approved a new class of drugs called aromatase inhibitors for older women suffering from breast cancer. The decision by the National Institute for Health and Clinical Excellence (NICE) means breast cancer patients in England and Wales with hormone-sensitive tumours will receive the drugs on the state-funded NHS.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read